TEST: Samsung Bioepis Hit With Denosumab Lawsuit

Some Of The Patents Covering Prolia/Xgeva Are Expiring Next Year

 
• By Urtė Fultinavičiūtė
  
Magnifying Glass with a question mark
(Shutterstock)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin